spending during the remaining of 2017, encouraging by signs of growth cylinders including consumption and exports growth subsequently led a GDP expansion of 3.3%2 in the first quarter of 2017. The Bank of

22.68% of the same period of previous year). The profit margin increased from the same period of previous year mainly because the significant growth in revenue. Due to large portion of fixed costs, the

-year performance which has already factored into the Company’s annual growth forecast. Meanwhile, we already have seen signs of improvement in overall advertising sentiment in upcoming November and

its overseas subsidiaries’ operation as well as continuing marketing and managing expense to support existing customers despite of reduced in sales growth as compared. 4. Financial Cost For the third

/2017 (for the equity holders of the Company) was THB 36.65 million, an increase of THB 8.85 million or of 31.83% from the same period last year (Q3/2017 : THB 27.80 million). The Growth in revenues and

the main trading currency of the company), resulting in the company recognized revenue from sales of foreign currency decreased For domestic market, revenue from sales increase lightly due to growth of

shares of Pek Industries Co., Ltd. at Baht 800.80 per share, totally Baht 5,600,000 for managing excess liquidity and gaining opportunity to invest in new business expecting good business growth. 10

Baht or 22.68% due to overall growth of the market. The company recorded domestic sales of 687.94 million Baht which increased from the same quarter last year totaling 162.91 million Baht or 31.03

opportunity to invest in new business expecting good business growth. 10) Opinions by Audit Committee - None - 11) Transaction Type : The Transaction as stated above would be within scope of the related

, medical device business is expected to be growth at an average rate of 8.5-10.0% per year. This growth will be supported by: (i) government policy, focused on promoting investment in the sector through the